 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 September 1999 | Volume 131 Issue 5 | Pages 363-375
Purpose: To review epidemiologic studies on the association between homocyst(e)ine level and risk for cardiovascular disease and the potential benefits of homocysteine-decreasing therapies.
Data Sources: Computerized and manual searches of the literature on total homocysteine levels and cardiovascular disease.
Study Selection: Prospective studies and major retrospective epidemiologic studies evaluating the association between homocyst(e)ine levels and cardiovascular disease and the association between blood levels or dietary intake of folate, vitamin B6, and vitamin B12 and cardiovascular disease.
Data Extraction: Relevant data on patient population, plasma homocyst(e)ine levels, duration of follow-up, and main results were extracted from studies that met the inclusion criteria.
Data Synthesis: The designs and results of studies included in this review are summarized. A formal meta-analysis was not performed because the studies were heterogeneous in method and design.
Conclusions: Results of epidemiologic studies suggest that moderately elevated plasma or serum homocyst(e)ine levels are prevalent in the general population and are associated with an increased risk for cardiovascular disease, independent of classic cardiovascular risk factors. Simple, inexpensive, nontoxic therapy with folic acid, vitamin B6, and vitamin B12 reduces plasma homocyst(e)ine levels. Although the association between homocyst(e)ine levels and cardiovascular disease is generally strong and biologically plausible, the data from the prospective studies are less consistent. In addition, epidemiologic observations of an association between hyperhomocyst(e)inemia and cardiovascular risk do not prove the existence of a causal relation. Therefore, the effectiveness of folate, vitamin B6, and vitamin B12 in reducing cardiovascular morbidity and mortality requires rigorous testing in randomized clinical trials. Several such trials are under way; their results may greatly affect cardiovascular morbidity and mortality, given the simplicity and low cost of vitamin therapy.
Author and Article Information
From McMaster University, Hamilton, Ontario, Canada; Clinical Research Institute of Montreal, Montreal, Quebec, Canada; and Royal Perth Hospital, Perth, Western Australia.
Grant Support: Dr. Eikelboom is the recipient of a Medical Research Fellowship from the Haematology Society of Australia and the University of Western Australia. Dr. Yusuf is the recipient of a Medical Research Council of Canada Career Scientist Award and holds a Heart and Stroke Foundation of Ontario research chair.
Requests for Reprints: Eva Lonn, MD, Preventive Cardiology and Therapeutics Program, McMaster University, HGH, McMaster Clinic, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada.
Current Author Addresses: Drs. Eikelboom, Lonn, and Yusuf: Preventive Cardiology and Therapeutics Program, McMaster University, HGH, McMaster Clinic, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada.
Dr. Genest: Clinical Research Institute of Montreal, 110 avenue des Pins ouest, Montreal, Quebec H2W 1R7, Canada.
Dr. Hankey: Department of Neurology, Royal Perth Hospital, Wellington Street, Perth 6001, Australia. REVIEW
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  C. Held, G. Sumner, P. Sheridan, M. McQueen, S. Smith, G. Dagenais, S. Yusuf, and E. Lonn Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART) Vascular Medicine, November 1, 2008; 13(4): 245 - 253. [Abstract] [PDF]
|
|
|
|
 |
|
 P Borrione, M Rizzo, A Spaccamiglio, R A Salvo, A Dovio, A Termine, A Parisi, F Fagnani, A Angeli, and F Pigozzi Sport-related hyperhomocysteinaemia: a putative marker of muscular demand to be noted for cardiovascular risk Br. J. Sports Med., November 1, 2008; 42(11): 594 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhou, G. H. Werstuck, S. Lhotak, Y. Y. Shi, V. Tedesco, B. Trigatti, J. Dickhout, A. K. Majors, P. M. DiBello, D. W. Jacobsen, et al. Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice FASEB J, July 1, 2008; 22(7): 2569 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lonn Homocysteine-Lowering B Vitamin Therapy in Cardiovascular Prevention--Wrong Again? JAMA, May 7, 2008; 299(17): 2086 - 2087. [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Moens, C. J. Vrints, M. J. Claeys, J.-P. Timmermans, H. C. Champion, and D. A. Kass Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H1971 - H1977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. E. Mann, P. Sheridan, M. J. McQueen, C. Held, J. M. O. Arnold, G. Fodor, S. Yusuf, E. M. Lonn, and on behalf of the HOPE-2 investigators Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study Nephrol. Dial. Transplant., February 1, 2008; 23(2): 645 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Jamison, P. Hartigan, J. S. Kaufman, D. S. Goldfarb, S. R. Warren, P. D. Guarino, J. M. Gaziano, and For the Veterans Affairs Site Investigators Effect of Homocysteine Lowering on Mortality and Vascular Disease in Advanced Chronic Kidney Disease and End-stage Renal Disease: A Randomized Controlled Trial JAMA, September 12, 2007; 298(10): 1163 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. H. Meng, G. Yang, W. Yang, B. Jiang, L. Wu, and R. Wang Protective Effect of Hydrogen Sulfide on Balloon Injury-Induced Neointima Hyperplasia in Rat Carotid Arteries Am. J. Pathol., April 1, 2007; 170(4): 1406 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pilote, K. Dasgupta, V. Guru, K. H. Humphries, J. McGrath, C. Norris, D. Rabi, J. Tremblay, A. Alamian, T. Barnett, et al. A comprehensive view of sex-specific issues related to cardiovascular disease Can. Med. Assoc. J., March 13, 2007; 176(6): S1 - S44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, P. Factor-Litvak, G. R. Howe, J. H. Graziano, P. Brandt-Rauf, F. Parvez, A. van Geen, and H. Ahsan Arsenic Exposure from Drinking Water, Dietary Intakes of B Vitamins and Folate, and Risk of High Blood Pressure in Bangladesh: A Population-based, Cross-sectional Study Am. J. Epidemiol., March 1, 2007; 165(5): 541 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Luchsinger, M.-X. Tang, J. Miller, R. Green, and R. Mayeux Relation of Higher Folate Intake to Lower Risk of Alzheimer Disease in the Elderly Arch Neurol, January 1, 2007; 64(1): 86 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. N. Pour, D. E Grobbee, M. Muller, M. Emmelot-Vonk, and Y. T van der Schouw Serum sex hormone and plasma homocysteine levels in middle-aged and elderly men Eur. J. Endocrinol., December 1, 2006; 155(6): 887 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Marciniak and D. Ron Endoplasmic reticulum stress signaling in disease. Physiol Rev, October 1, 2006; 86(4): 1133 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Groner, M. Joshi, and J. A. Bauer Pediatric Precursors of Adult Cardiovascular Disease: Noninvasive Assessment of Early Vascular Changes in Children and Adolescents Pediatrics, October 1, 2006; 118(4): 1683 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.M.L. de Lau, P. J. Koudstaal, J. C.M. Witteman, A. Hofman, and M. M.B. Breteler Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology, July 25, 2006; 67(2): 315 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sleight, H. Pouleur, and F. Zannad Benefits, challenges, and registerability of the polypill Eur. Heart J., July 2, 2006; 27(14): 1651 - 1656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Circulation, June 20, 2006; 113(24): e873 - e923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Aboyans, M. H. Criqui, J. O. Denenberg, J. D. Knoke, P. M Ridker, and A. Fronek Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels Circulation, June 6, 2006; 113(22): 2623 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke, June 1, 2006; 37(6): 1583 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The Heart Outcomes Prevention Evaluation (HOPE) 2 Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease N. Engl. J. Med., April 13, 2006; 354(15): 1567 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. O. Song, C.-E. Chung, O. K. Chun, and S. Cho Serum Homocysteine Concentration of US Adults Associated with Fortified Cereal Consumption J. Am. Coll. Nutr., December 1, 2005; 24(6): 503 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Dickhout, G. S. Hossain, L. M. Pozza, J. Zhou, S. Lhotak, and R. C. Austin Peroxynitrite Causes Endoplasmic Reticulum Stress and Apoptosis in Human Vascular Endothelium: Implications in Atherogenesis Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2623 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Dou, D. Xia, L. Zhang, X. Chen, P. Flores, A. Datta, and C. Yuan Development of a Novel Enzymatic Cycling Assay for Total Homocysteine Clin. Chem., October 1, 2005; 51(10): 1987 - 1989. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Weikert, K. Hoffmann, J. Dierkes, B.-C. Zyriax, K. Klipstein-Grobusch, M. B. Schulze, R. Jung, E. Windler, and H. Boeing A Homocysteine Metabolism-Related Dietary Pattern and the Risk of Coronary Heart Disease in Two Independent German Study Populations J. Nutr., August 1, 2005; 135(8): 1981 - 1988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Lichtenstein and R. M. Russell Essential Nutrients: Food or Supplements?: Where Should the Emphasis Be? JAMA, July 20, 2005; 294(3): 351 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schnabel, K. J. Lackner, H. J. Rupprecht, C. Espinola-Klein, M. Torzewski, E. Lubos, C. Bickel, F. Cambien, L. Tiret, T. Munzel, et al. Glutathione Peroxidase-1 and Homocysteine for Cardiovascular Risk Prediction: Results from the AtheroGene Study J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1631 - 1637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Joseph, R. H. Kennedy, S. Devi, J. Wang, L. Joseph, and M. Hauer-Jensen Protective role of mast cells in homocysteine-induced cardiac remodeling Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2541 - H2545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhou, S. Lhotak, B. A. Hilditch, and R. C. Austin Activation of the Unfolded Protein Response Occurs at All Stages of Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice Circulation, April 12, 2005; 111(14): 1814 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lee, J.-m. Kim, H. J. Kim, I. Lee, and N. Chang Folic Acid Supplementation Can Reduce the Endothelial Damage in Rat Brain Microvasculature Due to Hyperhomocysteinemia J. Nutr., March 1, 2005; 135(3): 544 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bosch-Marce, R. Pola, A. B Wecker, M. Silver, A. Weber, C. Luedemann, C. Curry, T. Murayama, M. Kearney, Y.-s. Yoon, et al. Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia Vascular Medicine, February 1, 2005; 10(1): 15 - 22. [Abstract] [PDF]
|
|
|
|
 |
|
 A S T Bickerton, N Clark, D Meeking, K M Shaw, M Crook, P Lumb, C Turner, and M H Cummings Cardiovascular risk in women with polycystic ovarian syndrome (PCOS) J. Clin. Pathol., February 1, 2005; 58(2): 151 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Crowther Pathogenesis of Atherosclerosis Hematology, January 1, 2005; 2005(1): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Martinez-Berriotxoa, G Ruiz-Irastorza, M-V Egurbide, M Rueda, and C Aguirre Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus Lupus, December 1, 2004; 13(12): 927 - 933. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Smolkova, M. Dusinska, K. Raslova, M. Barancokova, A. Kazimirova, A. Horska, V. Spustova, and A. Collins Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk Mutagenesis, November 1, 2004; 19(6): 469 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L Jamison, P. Hartigan, J M. Gaziano, S. P Fortmann, D. S Goldfarb, J. A Haroldson, J. Kaufman, P. Lavori, K. S McCully, and K. Robinson Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study Clinical Trials, October 1, 2004; 1(5): 451 - 460. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Vrentzos, J. A. Papadakis, N. Malliaraki, E. A. Zacharis, K. Katsogridakis, A. N. Margioris, P. E. Vardas, and E. S. Ganotakis Association of Serum Total Homocysteine with the Extent of Ischemic Heart Disease in a Mediterranean Cohort Angiology, September 1, 2004; 55(5): 517 - 524. [Abstract] [PDF]
|
|
|
|
|
|
G.J. Hankey, J.W. Eikelboom, K. Loh, Q. Yi, J. Pizzi, M. Tang, S. Hickling, M. Le, C.J. M. Klijn, P. Dusitanond, et al. Is There Really a Power Shortage in Clinical Trials Testing the "Homocysteine Hypothesis?" Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): e147 - e147. [Full Text] [PDF]
|
|
|
|
|
|
S. Dayal, E. Arning, T. Bottiglieri, R. H. Boger, C. D. Sigmund, F. M. Faraci, and S. R. Lentz Cerebral Vascular Dysfunction Mediated by Superoxide in Hyperhomocysteinemic Mice Stroke, August 1, 2004; 35(8): 1957 - 1962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Hankey and J. W. Eikelboom Folic Acid-Based Multivitamin Therapy to Prevent Stroke: The Jury Is Still Out Stroke, August 1, 2004; 35(8): 1995 - 1998. [Full Text] [PDF]
|
|
|
|
|
|
J. Zhou, G. H. Werstuck, S. Lhotak, A. B. L. de Koning, S. K. Sood, G. S. Hossain, J. Moller, M. Ritskes-Hoitinga, E. Falk, S. Dayal, et al. Association of Multiple Cellular Stress Pathways With Accelerated Atherosclerosis in Hyperhomocysteinemic Apolipoprotein E-Deficient Mice Circulation, July 13, 2004; 110(2): 207 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Samson, Z. Yungst, and D. P. Showalter Homocysteine, a Risk Factor for Carotid Atherosclerosis, Is Not a Risk Factor for Early Recurrent Carotid Stenosis Following Carotid Endarterectomy Vascular and Endovascular Surgery, July 1, 2004; 38(4): 345 - 348. [Abstract] [PDF]
|
|
|
|
 |
|
 D. L. McKay, J. M. Berkowitz, J. B. Blumberg, and J. P. Goldberg Communicating Cardiovascular Disease Risk Due to Elevated Homocysteine Levels: Using the EPPM to Develop Print Materials Health Educ Behav, June 1, 2004; 31(3): 355 - 371. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Skurk and K. Walsh Death Receptor Induced Apoptosis: A New Mechanism of Homocysteine-Mediated Endothelial Cell Cytotoxicity Hypertension, June 1, 2004; 43(6): 1168 - 1170. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Nurk, G. S Tell, S. E Vollset, O. Nygard, H. Refsum, R. M Nilsen, and P. M Ueland Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study Am. J. Clinical Nutrition, May 1, 2004; 79(5): 812 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Huijgen, F. P.W. Tegelaers, C. H.H. Schoenmakers, C. J. Pronk-Admiraal, and S. Ekema Multicenter Analytical Evaluation of an Enzymatic Method for the Measurement of Plasma Homocysteine and Comparison with HPLC and Immunochemistry Clin. Chem., May 1, 2004; 50(5): 937 - 940. [Full Text] [PDF]
|
|
|
|
|
|
R. Zhang, J. Ma, M. Xia, H. Zhu, and W. Ling Mild Hyperhomocysteinemia Induced by Feeding Rats Diets Rich in Methionine or Deficient in Folate Promotes Early Atherosclerotic Inflammatory Processes J. Nutr., April 1, 2004; 134(4): 825 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Devlin, E. Arning, T. Bottiglieri, F. M. Faraci, R. Rozen, and S. R. Lentz Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice Blood, April 1, 2004; 103(7): 2624 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Toole, M. R. Malinow, L. E. Chambless, J. D. Spence, L. C. Pettigrew, V. J. Howard, E. G. Sides, C.-H. Wang, and M. Stampfer Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death: The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial JAMA, February 4, 2004; 291(5): 565 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G C Icke, M Dennis, S Sjollema, D J Nicol, and J W Eikelboom Red cell N5-methyltetrahydrofolate concentrations and C677T methylenetetrahydrofolate reductase genotype in patients with stroke J. Clin. Pathol., January 1, 2004; 57(1): 54 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Troen, E. Lutgens, D. E. Smith, I. H. Rosenberg, and J. Selhub The atherogenic effect of excess methionine intake PNAS, December 9, 2003; 100(25): 15089 - 15094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Koch, G. Ndrepepa, J. Mehilli, S. Braun, M. Burghartz, H. Lengnick, K. Kolling, A. Schomig, and A. Kastrati Homocysteine Status and Polymorphisms of Methylenetetrahydrofolate Reductase Are Not Associated With Restenosis After Stenting in Coronary Arteries Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2229 - 2234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Balk, J. Lau, L. C. Goudas, H. S. Jordan, B. Kupelnick, L. U. Kim, and R. H. Karas Effects of Statins on Nonlipid Serum Markers Associated with Cardiovascular Disease: A Systematic Review Ann Intern Med, October 21, 2003; 139(8): 670 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Hossain, J. V. van Thienen, G. H. Werstuck, J. Zhou, S. K. Sood, J. G. Dickhout, A. B. L. de Koning, D. Tang, D. Wu, E. Falk, et al. TDAG51 Is Induced by Homocysteine, Promotes Detachment-mediated Programmed Cell Death, and Contributes to the Development of Atherosclerosis in Hyperhomocysteinemia J. Biol. Chem., August 8, 2003; 278(32): 30317 - 30327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. I Mennen, G. P. de Courcy, J.-C. Guilland, V. Ducros, M. Zarebska, S. Bertrais, A. Favier, S. Hercberg, and P. Galan Relation between homocysteine concentrations and the consumption of different types of alcoholic beverages: the French Supplementation with Antioxidant Vitamins and Minerals Study Am. J. Clinical Nutrition, August 1, 2003; 78(2): 334 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lalla, I. B. Lamster, M. A. Hofmann, L. Bucciarelli, A. P. Jerud, S. Tucker, Y. Lu, P. N. Papapanou, and A. M. Schmidt Oral Infection With a Periodontal Pathogen Accelerates Early Atherosclerosis in Apolipoprotein E-Null Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1405 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Article
